Profilo
Dr. Hella Kohlhof is a Chief Scientific Officer at Immunic, Inc. Dr. Kohlhof was previously employed as a Chief Science Officer by Vital Therapies, Inc., a Director-Projects Development by 4SC AG, and a Managing Director by Immunic Research GmbH.
She received her doctorate degree from Ludwig-Maximilians-Universität München.
Posizioni attive di Hella Kohlhof
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNIC, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2017 |
Precedenti posizioni note di Hella Kohlhof
| Società | Posizione | Fine |
|---|---|---|
Immunic Research GmbH | Amministratore Delegato | - |
| 4SC AG | Corporate Officer/Principal | - |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Hella Kohlhof
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
4SC AG
4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Immunic Research GmbH |
















